Skip to main content
Premium Trial:

Request an Annual Quote

Sterner Stuff

A new bill introduced by US Congressman Edward Markey (D-Mass.) to the House of Representatives calls for tougher reporting requirements to ClinicalTrials.gov, says Peter Mansell at PharmaTimes. The proposed legislation, called the Trial and Experimental Studies Transparency, or TEST, Act of 2012, would require that results from all clinical trials be posted to the database within a year of the trial's end. Additionally, it says that trials would need to be registered prior to enrolling any participants and that the National Institutes of Health and the Food and Drug Administration have to report to Congress on new database standards. Mansell adds that the bill also calls for sponsors of trials conducted outside the US, but that plan to market in the US, to also have to register with and report to the database.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.